Historique de carrière de Ashley Ivor Simon Morris
Anciens postes connus de Ashley Ivor Simon Morris
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SCIGEN LIMITED | Directeur/Membre du Conseil | 14/02/2017 | 08/09/2017 |
| Directeur Général | 09/02/2017 | 08/09/2017 | |
| MERCK SHARP DOHME PHARMA TBK PT | Corporate Officer/Principal | 01/01/2004 | 01/01/2009 |
Formation de Ashley Ivor Simon Morris
| The University of Nottingham | Undergraduate Degree |
Statistiques
Internationale
| Singapour | 2 |
| Royaume-Uni | 2 |
| Indonésie | 2 |
Opérationnelle
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MERCK SHARP DOHME PHARMA TBK PT | Health Technology |
| Entreprise privées | 1 |
|---|---|
SciGen Pte Ltd.
 SciGen Pte Ltd. Pharmaceuticals: MajorHealth Technology SciGen Pte Ltd. engages in the development, manufacturing, and marketing of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China, and Others. The Singapore segment comprises of corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and Philippines segments deal with sales and marketing activities. The China segment is involved in regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The firm's products include SciLin, SciTropin A, SciLocyte, SciTrace 5 Injection, and Heri Injection. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore. | Health Technology |
- Bourse
- Insiders
- Ashley Ivor Simon Morris
- Expérience
